ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Admi...
Q2 2026
Aug 5, 2026
Q1 2026
May 4, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 10, 2025